Namtip Srirak
Biographic Data
| ID | 1736647 |
|---|---|
| NAME | Namtip Srirak |
| GIVEN NAMES | Namtip |
| FAMILY NAME | Srirak |
| SIGNATURE | SRIRAK N |
| AFFILIATIONS | Chiang Mai University |
| VERIFIED | No |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 28 |
| WORKS AS AUTHOR | 5 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2003 |
| LATEST PUBLICATION YEAR | 2009 |
| H-INDEX | 2 |
A comparison of HIV stigma and discrimination in five international sites
Injection prevalence and risks among male ethnic minority drug users in northern Thailand
Thailand's rate of HIV due to drug use is increasing, and nearly one-half of clients at a drug treatment centre in the north are from marginalized ethnic minority groups. We describe and compare socio-demographics, drug use, and sexual practices across ethnic minority people presenting for treatment at the Northern Drug Treatment Center, Mae Rim, Thailand. A prevalence study was conducted between February 1999 and January 2000. Trained interviewe…
The influence of Thailand's 2003 ‘war on drugs’ policy on self-reported drug use among injection drug users in Chiang Mai, Thailand
Acceptability of a Microbicide Among Women and Their Partners in a 4-Country Phase I Trial
Objectives. We analyzed qualitative and quantitative data for 98 HIV-negative, low-risk women in Malawi, Zimbabwe, India, and Thailand who participated in a safety and acceptability study of BufferGel, a vaginal microbicide to determine the across-country acceptability of vaginal microbicides among women and their partners. Methods. Quantitative survey data were collected at 7 and 14 days after use among enrolled women, and exit interviews were c…
Drug Use, Increasing Incarceration Rates, and Prison-Associated HIV Risks in Thailand
A comparison of HIV stigma and discrimination in five international sites
Acceptability of a Microbicide Among Women and Their Partners in a 4-Country Phase I Trial
Objectives. We analyzed qualitative and quantitative data for 98 HIV-negative, low-risk women in Malawi, Zimbabwe, India, and Thailand who participated in a safety and acceptability study of BufferGel, a vaginal microbicide to determine the across-country acceptability of vaginal microbicides among women and their partners. Methods. Quantitative survey data were collected at 7 and 14 days after use among enrolled women, and exit interviews were c…
Drug Use, Increasing Incarceration Rates, and Prison-Associated HIV Risks in Thailand
Acceptability of a Microbicide Among Women and Their Partners in a 4-Country Phase I Trial
Objectives. We analyzed qualitative and quantitative data for 98 HIV-negative, low-risk women in Malawi, Zimbabwe, India, and Thailand who participated in a safety and acceptability study of BufferGel, a vaginal microbicide to determine the across-country acceptability of vaginal microbicides among women and their partners. Methods. Quantitative survey data were collected at 7 and 14 days after use among enrolled women, and exit interviews were c…
Injection prevalence and risks among male ethnic minority drug users in northern Thailand
Thailand's rate of HIV due to drug use is increasing, and nearly one-half of clients at a drug treatment centre in the north are from marginalized ethnic minority groups. We describe and compare socio-demographics, drug use, and sexual practices across ethnic minority people presenting for treatment at the Northern Drug Treatment Center, Mae Rim, Thailand. A prevalence study was conducted between February 1999 and January 2000. Trained interviewe…
The influence of Thailand's 2003 ‘war on drugs’ policy on self-reported drug use among injection drug users in Chiang Mai, Thailand
A comparison of HIV stigma and discrimination in five international sites
Medicine (5 works) · Environmental health (4 works) · HIV, Drug Use, Sexual Risk (4 works) · HIV/AIDS Research and Interventions (4 works) · Demography (3 works) · Population (3 works) · Psychiatry (3 works) · Sociology (3 works) · Adolescent Sexual and Reproductive Health (2 works) · Demography (2 works)